Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.


Sheba and Toronto General

Sheba and Toronto General Explore Lung Transplantation Advances in a Joint Conference

Clinicians from Toronto General Hospital joined Sheba’s experts at the second scientific conference arranged by Sheba’s Lung Transplant Program to explore advanced lung preservation and sterilization techniques before transplant. One of the most significant breakthroughs discussed was a new research demonstrating techniques to preserve lungs outside the donor’s body for up to 72 hours.  Procedures […]
Read More
Aknur story

From Harrowing Beginnings to a Happy Conclusion: Aknur’s Journey to Recovery

“Aknur was born prematurely when I was only 28 weeks pregnant,” recalled her mother, Diana. “As her lungs were not yet able to function on their own, she was on ventilation during her first two months, three weeks of which she spent in the NICU. Shortly after we were finally discharged, Aknur was diagnosed with […]
Read More

West Bank and Gaza Medical Professionals Attend a Milestone Sheba Oncology Conference

As part of the REACT 2023 regional conference, which took place on Monday, March 20th, Sheba’s premier physicians showcased the latest in oncologic care, focusing on pediatrics, marking a significant breakthrough for Israeli-Palestinian medical cooperation. A leader in clinical care, research, and innovation, Sheba is committed to not only offering world-class care to all patients, […]
Read More

Isenia’s Battle with Alveolar Sarcoma

At 17, Isenia, a native of Semey, Kazakhstan, noticed a lump on her leg the size of a small apple. Initially, Isenia and her family thought it to be a dancing-related injury. However, as months passed, the lump showed no signs of change, so Isenia decided to seek medical attention and was soon diagnosed with […]
Read More
Colon and Rectal Cancer patients post surgery stress-inflammatory response reduced with propranolol and etodolac.

Sheba Study Indicates Readily-Available Drugs May Prevent Metastasis in Colon and Rectal Cancer Patients

Favorable responses to the treatment were noted by Prof. Shamgar Ben-Eliyahu, a neuroscientist specializing in psychoneuroimmunology (PNI) at TAU’s Sagol School of Neuroscience and School of Psychological Sciences, and Prof. Oded Zamora of TAU’s Sackler Faculty of Medicine, who led the study. “Our treatment reduced markers of metastasis in the tumor tissue and decreased the […]
Read More
Drug discovery allows new treatment for ulcerative colitis

A New Drug Discovery and Personalized Treatment Approach for Ulcerative Colitis

Ulcerative colitis is a chronic disease of the large intestine in which the colon’s lining becomes inflamed and develops tiny open sores or ulcers that require lifelong treatment. Patients respond differently or fail to respond to therapies, resulting in their exposure to unnecessary drugs and a delay in the provision of an effective new treatment […]
Read More
cancer cell treatment with car t-cell therapy

Onsite CAR T-Cell Therapy Holds Significant Advantages for Cancer Patients, Despite Challenges 

CAR T-cell therapy is an advanced treatment for blood cancers, in which T-cells, also known as T-lymphocytes, which are a type of white blood cell involved in the body’s immune response, are re-engineered to attack malignant cells. This is accomplished by modifying the CAR receptors on T-cell membranes so that they bind to antigens on […]
Read More
Teen obesity increases risk of type 1 diabetes according to the latest study by Sheba Medical Center.

New Sheba Study Suggests: Teen Obesity Increases Risk of Type 1 Diabetes

Sheba researchers collected health data on nearly 1.5 million 17-year-olds (58% male, 42% female) who were given medical evaluations before they began Israeli military service in 1996, and then followed their health histories through 2016. At the beginning of the study, none of the subjects showed any abnormalities in blood sugar levels, but over the […]
Read More
Trametinib offers new hope in patients battling kaposiform lymphangiomatosis.

Trametinib: A Possible New Treatment for Severe Kaposiform Lymphangiomatosis

The lymphatic system, part of the immune system, is made up of vessels that help to protect the body from infection and foreign substances. It produces and releases lymphocytes (white blood cells) and other immune cells that monitor and then destroys pathogens — such as bacteria, viruses, parasites, and fungi — whenever they enter your […]
Read More